Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 244
7
Diseases
4
Unique genes
0.415
Avg. similarity score
Deafness, nonsyndromic sensorineural, mitochondrial
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Deafness, nonsyndromic sensorineural, mitochondrial
Ayazi syndrome
Choroideremia-deafness-obesity syndrome
Chromosome xq21 deletion syndrome
Xq21 microdeletion syndrome
Deafness, aminoglycoside-induced
Deafness, sensorineural, autosomal-mitochondrial type
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Deafness, nonsyndromic sensorineural, mitochondrial | 6 | 6 | 3 |
| Ayazi syndrome | 4 | 4 | 1 |
| Choroideremia-deafness-obesity syndrome | 4 | 4 | 1 |
| Chromosome xq21 deletion syndrome | 4 | 4 | 1 |
| Xq21 microdeletion syndrome | 4 | 4 | 1 |
| Deafness, aminoglycoside-induced | 2 | 2 | 3 |
| Deafness, sensorineural, autosomal-mitochondrial type | 2 | 2 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| POU3F4 | 5 / 7 | Ayazi syndrome, Choroideremia-deafness-obesity syndrome, Chromosome xq21 deletion syndrome, Deafness, nonsyndromic sensorineural, mitochondrial and 1 more |
| COX1 | 3 / 7 | Deafness, aminoglycoside-induced, Deafness, nonsyndromic sensorineural, mitochondrial, Deafness, sensorineural, autosomal-mitochondrial type |
| ND1 | 3 / 7 | Deafness, aminoglycoside-induced, Deafness, nonsyndromic sensorineural, mitochondrial, Deafness, sensorineural, autosomal-mitochondrial type |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Respiratory electron transport | Reactome | 2 / 83 | 72.3× | 2.81e-4 | 5.10e-3 ✓ sig. |
| Oxidative phosphorylation | KEGG | 2 / 137 | 43.8× | 7.64e-4 | 1.11e-2 ✓ sig. |
| Diabetic cardiomyopathy | KEGG | 2 / 205 | 29.3× | 1.70e-3 | 2.03e-2 ✓ sig. |
| Chemical carcinogenesis - reactive oxygen species | KEGG | 2 / 227 | 26.5× | 2.08e-3 | 2.35e-2 ✓ sig. |
| Thermogenesis | KEGG | 2 / 234 | 25.7× | 2.21e-3 | 2.46e-2 ✓ sig. |
| Parkinson disease | KEGG | 2 / 268 | 22.4× | 2.89e-3 | 3.00e-2 ✓ sig. |
| Prion disease | KEGG | 2 / 275 | 21.8× | 3.04e-3 | 3.10e-2 ✓ sig. |
| Huntington disease | KEGG | 2 / 308 | 19.5× | 3.80e-3 | 3.64e-2 ✓ sig. |
| Amyotrophic lateral sclerosis | KEGG | 2 / 368 | 16.3× | 5.39e-3 | 4.60e-2 ✓ sig. |
| Alzheimer disease | KEGG | 2 / 388 | 15.5× | 5.98e-3 | 4.92e-2 ✓ sig. |
| Pathways of neurodegeneration - multiple diseases | KEGG | 2 / 480 | 12.5× | 9.06e-3 | 6.47e-2 |
| Complex I biogenesis | Reactome | 1 / 55 | 54.6× | 1.82e-2 | 9.77e-2 |
| TP53 Regulates Metabolic Genes | Reactome | 1 / 86 | 34.9× | 2.83e-2 | 1.25e-1 |
| Cardiac muscle contraction | KEGG | 1 / 87 | 34.5× | 2.87e-2 | 1.26e-1 |
| Retrograde endocannabinoid signaling | KEGG | 1 / 149 | 20.2× | 4.87e-2 | 1.69e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| aerobic respiration | GO:0009060 | 2 / 68 | 137× | 7.79e-5 | 2.52e-3 ✓ sig. |
| response to hypoxia | GO:0001666 | 2 / 176 | 53.1× | 5.23e-4 | 9.86e-3 ✓ sig. |
| proton transmembrane transport | GO:1902600 | 2 / 181 | 51.6× | 5.53e-4 | 1.02e-2 ✓ sig. |
| tRNA wobble position uridine thiolation | GO:0002143 | 1 / 4 | 1,168× | 8.56e-4 | 1.36e-2 ✓ sig. |
| negative regulation of mesenchymal cell apoptotic process | GO:2001054 | 1 / 6 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |
| response to hydroperoxide | GO:0033194 | 1 / 9 | 519× | 1.93e-3 | 2.20e-2 ✓ sig. |
| response to copper ion | GO:0046688 | 1 / 12 | 389× | 2.57e-3 | 2.58e-2 ✓ sig. |
| mitochondrial electron transport, cytochrome c to oxygen | GO:0006123 | 1 / 23 | 203× | 4.91e-3 | 3.63e-2 ✓ sig. |
| respiratory electron transport chain | GO:0022904 | 1 / 23 | 203× | 4.91e-3 | 3.63e-2 ✓ sig. |
| response to electrical stimulus | GO:0051602 | 1 / 24 | 195× | 5.13e-3 | 3.71e-2 ✓ sig. |
| oxidative phosphorylation | GO:0006119 | 1 / 27 | 173× | 5.77e-3 | 3.94e-2 ✓ sig. |
| cochlea morphogenesis | GO:0090103 | 1 / 28 | 167× | 5.98e-3 | 4.01e-2 ✓ sig. |
| mitochondrial respiratory chain complex I assembly | GO:0032981 | 1 / 40 | 117× | 8.54e-3 | 4.72e-2 ✓ sig. |
| cellular respiration | GO:0045333 | 1 / 41 | 114× | 8.75e-3 | 4.79e-2 ✓ sig. |
| mitochondrial electron transport, NADH to ubiquinone | GO:0006120 | 1 / 47 | 99.4× | 1.00e-2 | 5.14e-2 |